ODDITY Tech Surges 9.66% on Q3 Earnings Beat and METHODIQ Launch: Is This the Catalyst for a New Bull Run?

Summary
• ODDITY Tech (ODD) rockets 9.66% intraday to $40.75, trading between $40.10 and $45.00.
• Q3 revenue jumps 24% to $148M, surpassing estimates, with gross margin expanding to 71.6%.
• METHODIQ, a telehealth platform for dermatology, debuts as a strategic growth driver.
• Options frenzy: 1.8M turnover, with ODD20251219C40 (40-strike call) seeing 54,673 shares traded. ODDITY Tech’s Q3 results and METHODIQ launch have ignited a bullish frenzy, with the stock surging 9.66% on robust revenue growth and margin expansion. The telehealth platform’s debut signals a pivot into high-margin healthcare tech, while options activity underscores speculative fervor.

Q3 Earnings Beat and METHODIQ Launch Ignite ODDITY’s Rally
ODDITY Tech’s 9.66% surge stems from a triple catalyst: Q3 revenue of $148M (+24% YoY) exceeding $145.44M estimates, gross margin expansion to 71.6% (+170 bps), and the launch of METHODIQ, a telehealth platform targeting $149M in Q4 revenue. CEO Oran Holtzman highlighted METHODIQ’s potential to ‘transform a broken medical care system,’ aligning with the company’s $806M–$809M full-year revenue guidance. The rally reflects investor optimism over margin resilience and new revenue streams in AI-driven healthcare.

Personal Products Sector Quiet as ODDITY Defies Trends
Options Playbook: Leverage ODDITY’s Volatility with Gamma-Driven Calls
• 200-day average: $56.64 (well below current price); RSI: 27.38 (oversold); MACD: -3.98 (bearish divergence).
• Bollinger Bands: $34.87–$49.08 (current price at 41.98, near lower band).
• Key levels: 200D support at $43.10–$43.92; 30D resistance at $51.03–$51.33.
• Leveraged ETF: N/A (data missing).

Top Options:
• ODD20251219C40 (Call, $40 strike, 12/19 expiry):
- IV: 79.54% (high volatility)
- Leverage ratio: 10.35%
- Delta: 0.567 (moderate sensitivity)
- Theta: -0.086 (rapid time decay)
- Gamma: 0.0427 (strong price sensitivity)
- Turnover: 54,673 (high liquidity)
- Payoff (5% upside): $0.535 per share (max(0, 42.79 - 40)).
- Why it stands out: High IV and gamma make it ideal for a short-term rally, with liquidity ensuring smooth entry/exit.
• ODD20251219C45 (Call, $45 strike, 12/19 expiry):
- IV: 62.49% (moderate volatility)
- Leverage ratio: 30.82%
- Delta: 0.309 (low sensitivity)
- Theta: -0.0579 (moderate time decay)
- Gamma: 0.0487 (strong price sensitivity)
- Turnover: 82,158 (high liquidity)
- Payoff (5% upside): $0.29 per share (max(0, 42.79 - 45)).
- Why it stands out: High leverage and gamma offer amplified returns if the rally continues, with lower delta reducing immediate risk.

Trading View: Aggressive bulls should target ODD20251219C40 into a break above $43.10 (200D support). If $45.00 holds, ODD20251219C45 offers leveraged exposure to a potential $47.00 breakout.

Backtest ODDITY Tech Stock Performance
I wasn’t able to retrieve any historical market data for the ticker symbol “ODD” (the data source returned an empty result). This usually means either • the ticker is incorrect / not supported by the data provider, or • the listing history is too short to cover the requested period (Jan-2022 → present).Could you please confirm:1. The exact ticker symbol you’d like me to analyse (e.g., if it trades under a different code or on a different exchange). 2. Whether you want the event trigger defined as: “day’s high is ≥ 10 % above the previous close,” or if you prefer another definition (e.g., close-to-close jump, open-to-close, etc.).Once I have this information, I can fetch the correct price series and proceed with the event back-test of post-surge performance.

ODDITY’s Rally: A Short-Term Catalyst or a New Trend?
ODDITY Tech’s 9.66% surge is fueled by Q3 outperformance and METHODIQ’s debut, but technicals suggest caution. RSI at 27.38 indicates oversold conditions, while Bollinger Bands near the lower bound hint at a potential rebound. The 200D average at $56.64 remains a distant target, but short-term momentum favors calls with high gamma and IV. Watch for a break above $43.10 (200D support) or a test of $45.00 (psychological level). Meanwhile, Estee Lauder (EL) rose 1.18%, underscoring the sector’s muted response. For ODDITY, the path forward hinges on sustaining Q3’s momentum and METHODIQ’s adoption. Aggressive bulls may consider ODD20251219C40 into a bounce above $43.10.